The global wound closure devices market size is expected to reach USD 25.19 billion by 2033, registering a CAGR of 6.31% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic injuries, technological advancements, and rising number of road accidents and surgeries are expected to propel market growth.
Rising incidence of road accidents across the globe has led to increase in demand for various wound closure devices. For instance, as per the reports on Road Traffic Injuries by WHO, every year 20 million to 50 million people suffer from some kind of injuries or disabilities resulting from road accidents. Moreover, increasing prevalence of burn and trauma cases globally is anticipated to drive the market. For instance, as per WHO (2018), around 1,000,000 people suffer from severe or moderate burns in India, each year. In addition, as per the National Center for Biotechnology Information (NCBI), in 2017, countries such as Bulgaria, Finland, the Netherlands, and China reported a rise in incidence of burn injuries. Wound closure devices, such as adhesives, staples, and sutures, are required for the treatment of such injuries.
North America held the largest market share in 2018 owing to the presence of key players in the region. Rising awareness among patients regarding the benefits of surgeries in providing quick relief from pains is driving regional growth. Key players operating in the North America market include B. Braun Melsungen AG; 3M; Medtronic; Johnson & Johnson Services, Inc.; and Baxter. The Asia Pacific market is expected to exhibit the fastest growth rate over the forecast period owing to surge of medical tourism.
Some of the products offered by key players are STRATAFIX suture by Johnson & Johnson, TISSEELfibrin sealant by Baxter, Biatain Adhesive and Biatain Ag Adhesive by Coloplast Corp., and APPOSE Single Use Skin Stapler by Medtronic.
Request a free sample copy or view report summary: Wound Closure Devices Market Report
Sutures dominated the market in 2025 due to their wide applicability across a broad range of surgical procedures and strong clinician familiarity.
Acute wounds led the market in 2025 and are expected to register the fastest growth during the forecast period, driven by the high incidence of surgical procedures, trauma cases, and emergency treatments.
Acute care hospitals dominated the market in 2025, driven by the high volume of surgical procedures, trauma cases, and emergency treatments performed in these settings.
Institutional sales dominated the market in 2025, driven by high procurement volumes from hospitals, surgical centers, and other healthcare facilities.
Prescribed products dominated the market in 2025, as most advanced closure solutions require clinical supervision and are used in surgical or hospital settings.
The wound closure devices industry in North America held the largest share and accounted for 39.27% of global revenue in 2025. This can be attributed due to evolving with a clear shift toward advanced, patient-centric solutions that improve healing outcomes and reduce procedure time.
Grand View Research has segmented the global wound closure devices market on the basis of product, wound, end use, distribution channel, mode of purchase, and region:
Wound Closure Devices Product Outlook (Revenue, USD Million, 2021 - 2033)
Sutures
Surgical Suture
Absorbable
Non-Absorbable
Barbed Suture (only Absorbable)
Uni-directional barbed suture
Bi-directional barbed suture
Gut Suture
Microsutures
Adhesives
Staples
Powered
Manual
Strips
By Sterility
Sterile
Non-Sterile
By Product
Reinforced Strips
Flexible Strips
Clips
Sealants
Non-Synthetic
Collagen Based
Synthetic
Topical Cyanoacrylates
Others
Others
Wound Closure Devices Wound Outlook (Revenue, USD Million, 2021 - 2033)
Acute Wounds
Surgical/ Procedure
Obstetrics / Gynecology
Colorectal
Cardiovascular
Bariatric and Upper GI
Plastic and Reconstructive Surgery
Urology
Hepato-pancreato-biliary (HPB)
Dermatology
Others
Lacerations & Minor Cuts
Burns
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Other Chronic Wounds
Wound Closure Devices End Use Outlook (Revenue, USD Million, 2021 - 2033)
Acute Care Hospital
Ambulatory Surgery Center (ASC)
Hospital Outpatient Wound Care Clinic
Home Healthcare
Skilled Nursing Facility (SNF)
Physician Office
Burn Center
Inpatient Rehabilitation Facility (IRF)
Long-term Acute Care Hospital (LTACH)
Long-term Care (residential living setting)
Wound Closure Devices Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Institutional Sales
Retail Sales
Wound Closure Devices Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
Prescribed
Non-prescribed (OTC)
Wound Closure Devices Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
Italy
France
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Wound Closure Devices Market
Solventum
3M
DeRoyal Industries, Inc.
DermaRite Industries, LLC.
B. Braun SE
Cardinal Health
Baxter
Stryker
Smith+Nephew
Medtronic
Ethicon (Johnson & Johnson)
Riverpoint Medical
DermaClip
Medline Industries, LP
Gentell
Dynarex Corporation
Corza Medical
Dukal, LLC
Aspen Surgical Products, Inc.
Essity Health & Medical (Essity)
Aero Healthcare
Healthium Medtech Ltd.
KitoTech Medical, Inc.
Trusetal Verbandstoffwerk GmbH
Advanced Medical Solutions Group plc
H.B. Fuller Medical Adhesive Technologies, LLC
AVITA Medical, Inc.
Meril
Terumo Corporation
CliniSut
Synthecon
Dolphin Sutures (Futura Surgicare Pvt Ltd)
Unisur Lifecare
AdvaCare Pharma
Suzhou Sunmed Co., Ltd.
Samyang Biopharm Corporation
Baihe Medical
MUB Medical.
BRIJ Medical
Southmedic Inc.
Sylke, Inc.
Clozex Medical, Inc.
DemeTECH
Teleflex (incl. Weck)
Lotus Surgicals
Internacional Farmaceutica
Serag-Wiessner
Lux Sutures
Chemence Medical
Intuitive Surgical
Frankenman
Reach Surgical (Genesis MedTech)
Purple Surgical
Grena Ltd
Ackermann Surgical
CSL Behring
Integra LifeSciences
Artivion (formerly CryoLife)
Takeda
McKesson Medical-Surgical
Mölnlycke Health Care
Paul Hartmann AG
Lohmann & Rauscher
"The quality of research they have done for us has been excellent..."